Ramosetron - PharmaKB

Ramosetron

Ramosetron is a small molecule pharmaceutical. It is currently being investigated in clinical studies.

Download report

Favorite

Events Timeline

Commercial

Clinical

Drug

Target

Variants

Financial

Trends

Safety

Events Timeline

YTD

Max

Events

FDA approval date

EMA approval date

Patent expiration date

Study first post date

Last update post date

Start date

Primary completion date

Completion date

Results first post date

Mock data
Subscribe for the real data

Commercial

No data

Clinical

Clinical Trials

66 clinical trials

View more details

Mock data
Subscribe for the real data

Indications Phases 4

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Irritable bowel syndrome	D043183	EFO_0000555	K58	—	2	3	2	1	8
Diarrhea	D003967	—	R19.7	—	2	2	2	1	7
Syndrome	D013577	—	—	—	2	3	2	—	7
Neoplasms	D009369	—	C80	—	—	1	1	—	2

Indications Phases 3

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Vomiting	D014839	—	R11.1	—	—	1	—	—	1
Nausea	D009325	—	R11.0	—	—	1	—	—	1

Indications Phases 2

No data

Indications Phases 1

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Healthy volunteers/patients	—	—	—	2	—	—	—	—	2

Indications Without Phase

No data

Epidemiology

Epidemiological information for investigational and approved indications

View more details

Drug

General

Drug common name	Ramosetron
INN	ramosetron
Description	Ramosetron is a member of indoles.
Classification	Small molecule
Drug class	serotonin 5-HT3 receptor antagonists
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)	Cn1cc(C(=O)[C@@H]2CCc3[nH]cnc3C2)c2ccccc21